New shot aims to help millions with hardened arteries
NCT ID NCT07318155
Summary
This study is testing a new injectable drug called SRSD107 for people with chronic coronary artery disease (CAD) or peripheral artery disease (PAD). The main goals are to see how the drug behaves in the body, if it's safe, and how it affects certain blood markers. About 104 participants will receive either the drug or a placebo (a dummy shot) while continuing their standard aspirin therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.